Pharmalog Institut fuer klinische Forschung
Pharmalog Institut fuer klinische Forschung is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
Menthacarin® in the treatment of functional gastrointestinal disorders
Sponsor Dr. Willmar Schwabe GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
Sponsor Abnoba GmbH
- Start (EU)
- Latest update
- Estimated end
Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency.
Sponsor MEDA Pharma GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
A phase I safety, dose finding and feasibility trial of MB-CART19.1 in patients with relapsed or refractory CD19 positive B cell malignancies
Sponsor Miltenyi Biomedicine GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Pharmalog Institut fuer klinische Forschung?
The 2026-10-09 snapshot links Pharmalog Institut fuer klinische Forschung to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Statistical analysis, Investigator recruitment, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Pharmalog Institut fuer klinische Forschung?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Pharmalog Institut fuer klinische Forschung conducted?
The linked trials record locations in 1 country, including Germany. These are trial locations, not confirmed office locations or countries where Pharmalog Institut fuer klinische Forschung delivered services.
What can this page tell me about Pharmalog Institut fuer klinische Forschung's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Pharmalog Institut fuer klinische Forschung. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Pharmalog Institut fuer klinische Forschung GmbH